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Introduction
Although today’s patients expect exact refractive results 
following cataract surgery, more than minimal residual 
refractive errors still occur in some cases.1 Current surgical 
treatment options for correction of pseudophakic residual 
refractive error include: intraocular exchange (IOL) exchange, 
laser refractive surgery, and implantation of a piggyback 
IOL.1,2,3 The piggyback technique has classically consisted of 
the implantation of a secondary, supplementary IOL in the 
sulcus or in the capsular bag anterior to the primary IOL.4,5 
Recently, piggyback IOLs, such as the Sulcoflex (Rayner 
Intraocular Lenses Ltd.), have been specifically designed for 
implantation in the ciliary sulcus.  
Removing the primary IOL can increase the risk of 
incurring capsular tears and zonular damage, IOL exchange is a 
procedure that is best performed during the early postoperative 
period before capsular bag fibrosis and adhesions occur.2,3 
Unlike IOL exchange, the piggyback technique can be safely 
performed at any time after cataract surgery.6,7 Piggyback IOLs 
also show good predictability and accuracy because the IOL 
power can be calculated without knowing the cause of the 
residual refractive error.1,2 Although laser refractive surgery 
is commonly used to enhance pseudophakic refraction, it is 
best performed in patients with normal corneal topography 
and a stable refractive error.8  Piggyback IOLs are an excellent 
treatment option for patients who are not suitable candidates 
for laser treatment, such as those with high refractive error, a 
history of radial or astigmatic keratotomy, as well as those with 
corneal pathologies not amenable to refractive surgery.8,9 The 
piggyback lens is also seen as an attractive alternative to laser 
treatment, as it is reversible and avoids the significant corneal 
healing that follows excimer laser ablation.1,9
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Purpose: To investigate the visual and refractive outcomes following implantation of a Sulcoflex intraocular 
lens (IOL) to correct pseudophakic refractive error.
Methods: This retrospective chart review included 14 pseudophakic eyes of 13 patients who underwent 
implantation of a Sulcoflex IOL. The Sulcoflex IOL is a piggyback IOL technique where a secondary, 
supplementary lens is implanted in the ciliary sulcus.
Results: Eleven eyes (78.6%) had a postoperative SE within 0.50 D of the targeted SE. Preoperative UDVA 
was 20/30 in 4 eyes (28.6%), and 20/40 or worse in 10 eyes (71.4%). Postoperative UDVA was 20/30 or 
better in all eyes, where half (50.0%) of eyes were 20/20 or better. The mean preoperative logMAR (0.50 ± 
0.33) significantly improved to 0.06 ± 0.09, p<.01. There were no complications.
Conclusions.  The significant improvement in UDVA and the precision in reaching the target refraction 
suggest that the Sulcoflex is a viable and successful treatment option for pseudophakic refractive error.
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The Sulcoflex lens was the first anterior chamber piggyback 
IOL commercially available for the correction of both spherical 
and astigmatic refractive errors, and can provide patients with 
near or distance vision.4,10 In addition, Sulcoflex zonal refractive 
multifocal IOLs are available for the correction of presbyopia 
so as to provide patients freedom from spectacles.11,12 The 
purpose of this study was to investigate the safety and visual 
and refractive outcomes following implantation of the 
Sulcoflex lens to correct pseudophakic residual refractive error 
after routine cataract surgery.
Methods
Study Design and Sample Recruitment
This retrospective case series investigated the outcomes of 
patients who received implantation of a Sulcoflex IOL to 
correct residual refractive error following cataract surgery. 
This study included 14 pseudophakic eyes of 13 patients 
that received implantation of either a Sulcoflex aspheric IOL 
(Rayner 653L) or a Sulcoflex toric IOL (Rayner 653T) in the 
ciliary sulcus between October 2011 and June 2014 at the 
Gimbel Eye Centre in Calgary, Alberta. Patients with previous 
radial or astigmatic keratotomy were excluded due to possible 
diurnal visual fluctuations affecting the refractive outcome 
assessment. Patients who received implantation of Sulcoflex 
Multifocal IOLs were also excluded, as the scope of this study 
was limited to refractive outcome only. Data including target 
refraction, preoperative refraction and uncorrected distance 
visual acuity (UDVA) were collected. Postoperative refraction 
and UDVA data were collected at least 1 month after 
Sulcoflex implantation to ensure stability of visual outcomes. 
All participants provided informed consent for the surgical 
procedure, data collection and the establishment of a database.
IOL Model Selection and Power Calculations
The Sulcoflex is the first commercially available IOL specifically 
designed for secondary implantation in the ciliary sulcus.13 It 
is a one-piece hydrophilic acrylic IOL that is 14mm in haptic 
diameter and 6.5mm in optic diameter.14 The anterior convex 
and posterior concave lens configuration allow for adequate 
space between both IOLs, while its undulating haptics with 
10° of angulation allow for adequate uveal clearance.10,13 The 
Sulcoflex IOL is currently manufactured in aspheric, toric, and 
multifocal models. The Rayner 653L lens power is available 
from -10.00 to +10.00 D, and the Rayner 653T ranges from 
-7.00 to +7.00 D with cylinders between +1.00 to +6.00 D.14 
The Sulcoflex is not yet approved in Canada and was obtained 
with Health Canada approval. IOL types were selected based 
on the individual’s refraction, lifestyle and needs. The IOL 
power and alignment was determined using Rayner’s online 
IOL power calculator (Raytrace). 
Surgical Technique
One surgeon, Dr. Howard Gimbel, performed all surgeries 
under topical and intracameral anesthetic. Eye-dependent 
incisions were made at variable meridians so as not to surgically 
induce or worsen pre-existing astigmatism. Sulcoflex IOLs were 
placed in the ciliary sulcus using the supplied injector. Good IOL 
centration was ensured. Toric IOLs were rotated into position 
by exact alignment of the reference marks on the toric IOL with 
corneal axis marks that were made prior to surgery. The wounds 
were watertight requiring no sutures. Patients were taken to 
the recovery room, and discharged when stable. Patients were 
instructed on postoperative ophthalmic medications.
Statistical Analysis
Mean, standard deviation, frequency, and percentage were 
used for descriptive statistics. For visual acuity evaluation, 
Snellen scale values were converted to logMAR notation. 
The Student paired t-test was used to compare preoperative 
and postoperative UDVA. The paired t-test was also used to 
compare the preoperative spectacle corrected distance visual 
acuity (SCDVA) with the postoperative UDVA, as a reference 
indicator to the efficacy of the Sulcoflex lens implantation. 
P-values less than 0.05 were considered statistically significant. 
Statistical analyses were conducted using SPSS version 21. 
Results
This study included 7 women and 6 men of mean age 64 years 
(range 49 to 82 years). Table 1 shows patient demographics, 
as well as the type and power of the implanted Sulcoflex IOL. 
Of 8 aspheric and 6 toric IOLs, the mean IOL power was -0.36 
D ± 3.93 (range -9.00 to +5.00 D). The time between primary 
surgery and Sulcoflex implantation was less than 1 year in 8 
eyes (57.1%), between 1 and 5 years in 3 eyes (21.4%), and 
over 5 years in 3 eyes (21.4%), ranging from 7 months to 18 
years. Postoperative follow-up visits ranged from 1.2 months 
to 14.6 months after surgery. 
The mean spherical equivalent (SE) decreased from 0.16 
D ± 2.54 (range -5.13 to +3.00 D) preoperatively to -0.28 
D  ± 0.60 (range -1.00 to +1.38 D) postoperatively.  The 
mean target SE was -0.15 D ± 0.21 (range -0.50 to 0.00 D). 
The postoperative SE was within 0.25 D of the targeted SE in 
7 eyes (50.0%), 0.50 D in 11 eyes (78.6%), 0.75 D in 13 eyes 
(92.9%), and had a greater than 1.00 D difference in 1 eye (7.1%). 
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Eye Age (Y) Gender IOL Type IOL Power (D) Time between primary and 
secondary surgery (years)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
52
69
65
56
68
65
73
75
49
82
75
53
62
58
F
M
M
F
F
M
F
F
M
F
F
M
M
M
RAY653T
RAY653L
RAY653L
RAY653L
RAY653L
RAY653L
RAY653L
RAY653L
RAY653T
RAY653L
RAY653T
RAY653T
RAY653T
RAY653T
+0.50
+3.00
+2.50
+2.50
+3.00
+2.50
-2.00
-5.00
-4.50
+5.00
-1.00
+0.50
-3.00
-9.00
0.85
0.70
0.81
1.73
0.76
0.81
1.30
8.38
0.63
18.02
0.94
1.79
0.55
11.55
Eye Preoperative Refraction Postoperative Refraction
1
2
3
4
5
6
7
8
9
10
11
12
13
14
+3.25 -0.50 x 67
+2.25 -0.50 x 158
+2.25 0.00 x 0
+2.00 -0.25 x 74
+2.00 -0.25 x 30
+1.50 -0.25 x 146
-1.25 -1.25 x 85
-4.25 -0.75 x 52
+2.50 -2.00 x 165
+1.25 -1.00 x 67
+1.25 -2.25 x 95
+1.00 -0.50 x 50
-1.00 -1.25 x 124
-3.25 -3.75 x 4
-0.75 -0.25 x 66
0.00 -0.25 x 180
plano
0.00 -0.50 x 15
+0.25 -0.25 x 50
-0.25 -0.50 x 100
-0.25 -0.25 x 65
+0.50 -1.00 x 75
+0.75 -0.50 x 133
+0.25 -0.25 x 55
-0.50 -0.50 x 48
-0.50 -0.25 x 171
+1.75 -0.75 x 89
-0.25 -0.25 x 90
Eye Targeted spherical 
equivalent
Postoperative spherical 
equivalent
Difference between Targeted 
and Postoperative SE
1
2
3
4
5
6
7
8
9
10
11
12
13
14
-0.25
-0.10
-0.50
0.00
0.00
-0.50
0.00
0.00
-0.50
0.00
-0.25
0.00
0.00
0.00
-0.88
-0.13
0.00
-0.25
0.13
-0.50
-0.38
0.00
-0.50
0.13
-0.75
-0.63
+1.38
-0.38
-0.63
-0.03
+0.50
-0.25
+0.13
0.00
-0.38
0.00
0.00
+0.13
-0.50
-0.63
+1.38
-0.38
Table 1. Patient demographics and Sulcoflex intraocular lens (IOL) selection.
Table 2. Patient preoperative and postoperative refraction.
Table 3. Targeted spherical equivalent and postoperative spherical equivalent by patient, in diopters (D).
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As shown in Table 2, the preoperative UDVA was 20/30 in 
4 eyes (28.6%), 20/40 in 2 eyes (14.3%), and was worse than 
20/40 in 8 eyes (57.1%). The postoperative UDVA was 20/20 
or better in 7 eyes (50.0%), 20/25 in 4 eyes (28.6%) and 
20/30 in 3 eyes (21.4%). All patients had improved UDVA 
postoperatively. (Figure 1) The mean UDVA significantly 
improved from 0.50 ± 0.33 logMAR preoperatively to 
0.06 ± 0.09 logMAR postoperatively, p<.01. There was no 
significant difference found when comparing the preoperative 
SCDVA (0.05 ± 0.12 logMAR) with the postoperative UDVA 
(0.06 ± 0.09 logMAR), p>0.05. 
No intraoperative or postoperative complications 
occurred in any case. There were no signs of pigment 
dispersion, Elschnig pearl formation, or interlenticular 
opacification observed during follow-up. Rotational stability 
and centration were excellent in all but one toric IOL case, 
which required a lens rotation 4 months postoperatively. After 
secondary surgery, the patient’s vision stabilized at 20/20. 
Postoperatively, two eyes had a neodymium-doped yttrium 
aluminum garnet (Nd:YAG) laser capsulotomy for posterior 
capsular opacification. These capsulotomies were safely and 
successfully performed through both the Sulcoflex and the 
primary IOL. 
One eye had a +1.38 D difference between the target SE 
and the postoperative SE. The refraction was +0.50 sphere 
one day postoperatively, however, by 6 months the refraction 
had gradually drifted more hyperopic. It is believed that 
the primary IOL had shifted in position due to capsular 
contraction, since a shift in the original +30.0 D lens would 
cause a greater change in refraction than the -3.00 D Sulcoflex 
lens. Upon further examination, it was found that the Sulcoflex 
IOL did have some rotation. However, the rotation does not 
have a great effect on the refraction, and is only an interesting 
coincidence. 
Discussion
The findings of our study suggest that piggyback IOL 
implantation in the ciliary sulcus is a safe and viable option 
for the treatment of pseudophakic refractive error. 
Similar to our findings, a study in the United Kingdom 
found a significant improvement in the spherical equivalent 
and uncorrected distance visual acuity after Sulcoflex 
implantation.15  In a sample of 15 eyes, all eyes had achieved 
a postoperative UDVA of 20/32 or better within 3 months 
with 10 (67%) eyes achieving 20/20 or better. Falzon et al15 
also found that 14 (93%) eyes of were within 0.5 D of the 
target refraction. Our study findings contribute to the current 
evidence regarding the efficacy of the Sulcoflex IOL to enhance 
refractive outcomes and reduce spectacle dependence for 
distance vision in pseudophakic eyes. 
In our study, the postoperative spectacle corrected distance 
visual acuity was found to be comparable to postoperative 
distance visual acuity, which also suggests that the Sulcoflex 
IOL is an effective way to provide cataract patients freedom 
from spectacles. Given the treatment options available, 
some patients may choose to wear spectacles over receiving 
the secondary surgery. However, pseudophakic patients 
with anisometropia or significant residual ametropia would 
benefit from this procedure. Depending on the patient’s 
demands for near and intermediate tasks, some patients may 
still require reading spectacles. The Sulcoflex IOL can be safely 
implanted after a long-term postoperative period, and as early 
as 3 months after primary cataract surgery if the refraction is 
deemed stable. 
Although the Sulcoflex piggyback IOL appears to be a more 
predictable and safer option than the IOL exchange procedure, 
a past concern with the classic implantation of piggyback IOLs 
in the capsular bag was the possible formation of interlenticular 
opacification (ILO).16,17 ILO is opacification that occurs 
Range from targeted SE Number of eyes (n=14)
±0.25 D
±0.50 D
±0.75 D
> 1.00 D
7 (50.0%)
11 (78.6%)
13 (92.9%)
1 (7.1%)
Table 4. The frequency of eyes whose postoperative spherical 
equivalent within range from the targeted spherical equivalent.
Figure 1. Patient preoperative and postoperative uncorrected 
distance visual acuity (UDVA).
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between the opposing lens surfaces and is a complication that 
can cause a significant decrease in vision as well as a possible 
hyperopic shift.17 Studies have demonstrated that implanting 
the piggyback lens in the ciliary sulcus instead of in the bag has 
been shown to reduce the risk of central optic touch.13 Since the 
development of lenses specifically designed for safe placement 
in the ciliary sulcus, the piggyback technique has regained 
attention for pseudophakic patients seeking to correct residual 
refractive errors. Although several different piggyback IOLs 
have been used, IOLs specifically designed for sulcus fixation, 
such as the Sulcoflex IOL are recommended. The round and 
smooth optic and haptic edges of the Sulcoflex lens reduce the 
risk of complications associated with single-piece IOLs with 
square, thick edges, such as pigmentary dispersion.4 There are 
also other alternative, commercially available piggyback IOL 
options designed for sulcus-placement, such as the Add-On 
(HumanOptics) and the 1st Add-On (1st Q Deutschland 
GmbH & Co.) IOLs. 
The small sample size should be considered when 
interpreting the findings of this study. More studies are needed 
confirm the reliability and efficacy of this novel approach 
to correcting pseudophakic refractive error. A much larger 
sample could increase the statistical power as well as adjust 
for factors such as sociodemographic characteristics, IOL type 
and power, as well as the degree of residua ametropia. Further 
studies are also necessary to better understand the long-term 
outcomes of Sulcoflex IOL implantation.
In conclusion, the findings of our study suggest that the 
Sulcoflex piggyback IOL is an effective treatment option for 
refractive errors or enhancement of postsurgical results, and 
can provide cataract patients freedom from spectacles many 
years after cataract surgery. 
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